Printer Friendly

The Assistance Fund to Provide Financial Assistance to Atypical Hemolytic-Uremic Syndrome Patients.

M2 PHARMA-January 10, 2018-The Assistance Fund to Provide Financial Assistance to Atypical Hemolytic-Uremic Syndrome Patients

(C)2018 M2 COMMUNICATIONS

- Orlando, Florida-based independent charitable patient assistance foundation The Assistance Fund has initiated a program to provide financial support to patients with atypical hemolytic-uremic syndrome, the company said.

The new fund will assist individuals with out-of-pocket medical expenses associated with their condition and treatment, including copayments and coinsurance, health insurance premiums and incidental medical expenses.

People with atypical hemolytic-uremic syndrome experience kidney damage and acute kidney failure that lead to end-stage renal disease in about half of all cases.

The condition can occur at any age and is estimated to affect 1 in 500,000 people per year in the United States.

The Assistance Fund helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses.

It currently manages more than 30 funds, each of which covers the FDA-approved medications that treat a specific disease. Since its founding in 2009, The Assistance Fund has helped more than 43,000 adults and children access the medicines they need to stay healthy or manage a chronic condition.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Jan 10, 2018
Words:205
Previous Article:ICON Appoints Dr. James Cummings as president of ClinicalRM.
Next Article:ArTara Therapeutics Names Randall Marshall, MD as Chief Medical Officer.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters